| Key Financial Ratios of Tatva Chintan Pharma Chem (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
0.14 |
12.82 |
18.26 |
44.65 |
25.57 |
|
| Diluted EPS (Rs.) |
0.14 |
12.82 |
18.26 |
44.65 |
25.57 |
|
| Cash EPS (Rs.) |
11.96 |
23.49 |
22.57 |
47.00 |
28.92 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
308.36 |
310.31 |
227.74 |
211.54 |
80.61 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
308.36 |
310.31 |
227.74 |
211.54 |
80.61 |
|
| Dividend / Share(Rs.) |
1.00 |
2.00 |
2.00 |
2.00 |
5.00 |
|
| Revenue from Operations/Share (Rs.) |
156.64 |
161.88 |
181.84 |
193.01 |
144.96 |
|
| PBDIT/Share (Rs.) |
12.57 |
31.79 |
27.23 |
52.46 |
34.99 |
|
| PBIT/Share (Rs.) |
0.75 |
20.85 |
22.92 |
48.77 |
31.64 |
|
| PBT/Share (Rs.) |
0.20 |
18.07 |
17.52 |
46.59 |
29.54 |
|
| Net Profit/Share (Rs.) |
0.14 |
12.55 |
18.26 |
43.31 |
25.57 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
8.02 |
19.64 |
14.97 |
27.17 |
24.13 |
|
| PBIT Margin (%) |
0.47 |
12.87 |
12.60 |
25.26 |
21.82 |
|
| PBT Margin (%) |
0.12 |
11.16 |
9.63 |
24.13 |
20.38 |
|
| Net Profit Margin (%) |
0.08 |
7.75 |
10.03 |
22.43 |
17.63 |
|
| Return on Networth / Equity (%) |
0.04 |
4.04 |
8.01 |
20.47 |
31.71 |
|
| Return on Capital Employed (%) |
0.24 |
6.70 |
9.95 |
22.39 |
32.97 |
|
| Return on Assets (%) |
0.03 |
3.60 |
5.36 |
14.71 |
16.58 |
|
| Total Debt/Equity (X) |
0.05 |
0.02 |
0.34 |
0.26 |
0.47 |
|
| Asset Turnover Ratio (%) |
0.45 |
0.48 |
0.57 |
0.89 |
1.05 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
2.51 |
3.37 |
1.27 |
2.53 |
1.53 |
|
| Quick Ratio (X) |
1.28 |
1.71 |
0.65 |
1.58 |
0.94 |
|
| Inventory Turnover Ratio (X) |
2.74 |
2.56 |
1.38 |
2.22 |
2.38 |
|
| Dividend Payout Ratio (NP) (%) |
1,430.58 |
15.93 |
10.95 |
0.00 |
7.82 |
|
| Dividend Payout Ratio (CP) (%) |
16.71 |
8.51 |
8.86 |
0.00 |
6.91 |
|
| Earnings Retention Ratio (%) |
-1,330.58 |
84.07 |
89.05 |
0.00 |
92.18 |
|
| Cash Earnings Retention Ratio (%) |
83.29 |
91.49 |
91.14 |
0.00 |
93.09 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,612.66 |
2,502.58 |
3,826.36 |
5,060.21 |
0.00 |
|
| EV/Net Operating Revenue (X) |
4.40 |
6.61 |
9.49 |
11.83 |
0.00 |
|
| EV/EBITDA (X) |
54.84 |
33.65 |
63.40 |
43.52 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
4.33 |
6.67 |
9.17 |
11.96 |
0.00 |
|
| Retention Ratios (%) |
-1,330.58 |
84.06 |
89.04 |
0.00 |
92.17 |
|
| Price/BV (X) |
2.20 |
3.48 |
7.32 |
10.91 |
0.00 |
|
| Price/Net Operating Revenue |
4.33 |
6.67 |
9.17 |
11.96 |
0.00 |
|
| Earnings Yield |
0.00 |
0.01 |
0.01 |
0.02 |
0.00 |
|
Source : Dion Global Solutions Limited
